Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451431) titled 'Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain' on Feb. 28.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Bangladesh Medical University

Condition: Diabetic Peripheral Neuropathic Pain (DPNP)

Intervention: Drug: Mirogabalin

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: October 1, 2025

Target Sample Size: 78

Countries of Recruitment: Bangladesh

To know more, visit https://clinicaltrials.gov/study/NCT07451431 ...